All In MedTech

Device Trial Radar · NCT00905645

Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study

Sientra Sponsored Silimed Gel-Filled Mammary Implant Clinical Study Protocol: Core Clinical Investigation

Last checked: Nov 20, 2026Latest source record: Jan 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

1,788

Actual

Start

Nov 2002

Primary completion

Dec 2018

Study completion Dec 2018

Sponsor

Lead sponsor
Tiger Biosciences, LLC.Not on our public-company list
Sponsor type
Industry
First posted
May 20, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Safety and effectiveness of the Silimed Gel-Filled Mammary Implant as indicated for primary augmentation, primary reconstruction, and/or revision of the female breast.

Conditions

  • Breast Augmentation
  • Breast Reconstruction
  • Breast Revision

Interventions

  • Silimed Gel-Filled Mammary ImplantDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Local ComplicationsTime frame: 10 Years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sientra, Inc.

    Santa Barbara, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.